Viral Clearance Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Viral Clearance Services Market is segmented by Method (Viral Removal, Viral Inactivation), by Application, by End-User, and by Geography.

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 15 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors attributing to the growth of the market are the rising need for viral clearance and increasing demand for specialty drugs. Viral clearance service guarantees the safe development of a biological product. Rising demand for virus inactivation or viral removal in products, increasing the need for detection of virus at the early stages of development of the drug, growing research and development activities are factors driving the market. 

Furthermore, the integration of technology in the field of biology such as chromatography, and nanofiltration helps in regulating the level of virus clearance. Thus, many pharmaceutical companies are concentrating on heavy investments in research and development activities for streamlining the regulations for viral safety. All such factors boosting the global viral clearance service market. However, lack of approval of outsourcing the preclinical procedures and activities from the various biopharmaceutical organizations is a restraint to the market.

Scope of the Report

As per the scope of the report viral clearance services include removal of viruses or bacteria that have been unintentionally left behind on the production equipment and biological products. These services include testing the end-products and equipment for any viruses, ensuing in safe and consistent development of biological products.

By Method
Viral Removal
Viral Inactivation
By Application
Recombinant Proteins
Tissue and Blood Derived Products
Vaccines
Others
By End-User
Biopharmaceuticals
Contract Research Organizations
Academic Research Institutes
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Recombinant Proteins Segment is Expected to Dominate the Market During the Forecast Period

Large-scale recombinant protein production is becoming progressively critical for applications in the field of proteomics, structural biology and protein therapeutics. When large quantities of protein need to be produced cells must be cultured in large volume by the implementation of fermentation techniques. As the production of these proteins increases the demand for the viral clearance process also increases.

The major factors driving the growth of the segment are the increasing demand for biopharmaceuticals for treating chronic conditions like diabetes cancers, and these drugs are forging their ways in the field of inflammatory disease management, such as psoriasis, multiple sclerosis, rheumatic diseases, and inflammatory bowel diseases. The introduction of recombinant proteins has revolutionized the development and manufacturing processes of biotherapeutics. The number of recombinant drugs is expected to grow further as multiple biologics and vaccines consisting of recombinant proteins are currently in the pipeline and are expected to get FDA approval. Thus, considering all the above mentioned factors the market is expected to grow.

Drug approval.png

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall viral clearance services market, throughout the forecast period. The largest share is mainly due to the presence of key players and their usage of advanced medical technologies to develop. The rise in the production of recombinant proteins, vaccines and the necessity to keep them risk-free and virus-free, is the major factor for the growth of the market. Furthermore, growing awareness among the population to use biopharmaceuticals and thus increasing demand for viral clearance service.

Venipuncture Needles and Syringes Market

Competitive Landscape

The viral clearance services market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Charles River, Labor Dr. Merk & Kollegen GmbH, Texcell, Merck KGaA, WuXi AppTec, Sartorius AG, Eurofins Scientific, Bioscience Laboratories, Syngene and Vironova.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Need of Viral Clearance

      2. 4.2.2 Rise in Research and Development Funding

      3. 4.2.3 Growing Demand for Specialty Drugs

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Approval of Outsourcing of Preclinical Procedures

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Method

      1. 5.1.1 Viral Removal

      2. 5.1.2 Viral Inactivation

    2. 5.2 By Application

      1. 5.2.1 Recombinant Proteins

      2. 5.2.2 Tissue and Blood Derived Products

      3. 5.2.3 Vaccines

      4. 5.2.4 Others

    3. 5.3 By End-User

      1. 5.3.1 Biopharmaceuticals

      2. 5.3.2 Contract Research Organizations

      3. 5.3.3 Academic Research Institutes

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Charles River Laboratories, Inc.

      2. 6.1.2 Labor Dr. Merk & Kollegen GmbH

      3. 6.1.3 Merck KGaA

      4. 6.1.4 Texcell SA

      5. 6.1.5 WuXi AppTec

      6. 6.1.6 Sartorius AG

      7. 6.1.7 Eurofins Scientific

      8. 6.1.8 Bioscience Laboratories

      9. 6.1.9 Vironova

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Viral Clearance Services Market market is studied from 2018 - 2026.

The Viral Clearance Services Market is growing at a CAGR of 15% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Charles River, Labor Dr. Merk & Kollegen GmbH, Merck KGaA, Texcell, WuXi AppTec are the major companies operating in Viral Clearance Services Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!